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Abstract
During critical periods of development early in life, excessive or scarce nutritional environments 
can disrupt the development of central feeding and metabolic neural circuitry, leading to obesity 
and metabolic disorders in adulthood. A better understanding of the genetic networks that control 
the development of feeding and metabolic neural circuits, along with knowledge of how and 
where dietary signals disrupt this process, can serve as the basis for future therapies aimed at 
reversing the public health crisis that is now building as a result of the global obesity epidemic. 
This review of animal and human studies highlights recent insights into the molecular mechanisms 
that regulate the development of central feeding circuitries, the mechanisms by which gestational 
and early postnatal nutritional status affects this process, and approaches aimed at counteracting 
the deleterious effects of early over- and underfeeding.
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INTRODUCTION
Over the past 30 years, global rates of obesity and comorbid health problems like type 2 
diabetes (T2D), cardiovascular disease, and cancer have increased dramatically (1). The 
scale of this problem is staggering. An estimated 43 million children were estimated to be 
overweight or obese in 2010, and this number is estimated to increase to 60 million by 2020 
(2). Increased body weight has moved in lockstep with pediatric prevalence of T2D, which 
now accounts for almost half of all child and adolescent diabetics (3).
Although economic and lifestyle changes, such as increased availability of high-calorie food 
and reduced physical activity, undoubtedly underlie these changes, developmental changes 
resulting from early-life overnutrition compound the problem. It has long been known that 
both under- and overfeeding during gestation or early childhood substantially increase the 
risk of obesity and comorbid diseases in adulthood (4, 5), a phenomenon referred to as 
metabolic imprinting (6). The lag between childhood and the onset of adult obesity suggests 
that permanent changes in central feeding circuitries, induced by maternal diet and 
adiposity, play an important part in driving the obesity epidemic (7).
This public health crisis provides the backdrop for this review, which covers two closely 
linked topics. First, because the central homeostat regulating feeding and metabolism is 
located in the brain, we review how neuronal feeding and metabolism circuitry is formed 
during embryonic and early postnatal development. Second, we review the long-term effects 
of developmental exposure to nutritional excess or scarcity, paying particular attention to 
how metabolic signals modulate the development of neural circuitry regulating feeding and 
metabolism.
OVERVIEW OF CENTRAL NEURAL CIRCUITRY REGULATING FEEDING 
AND METABOLISM
The hypothalamus is the key brain region that detects internal nutrient levels and uses this 
information to control feeding behavior. Neurons of the hypothalamic arcuate nucleus 
(ArcN) respond directly to circulating hunger- and satiety-promoting signals. The peptide 
hormone ghrelin, the most potent hunger-promoting peripheral substance identified, is 
released into the circulation by P/1D cells of the stomach fundus and pancreatic epsilon cells 
in response to low nutrient levels. Upon binding to the Gshr1a receptor, ghrelin rapidly 
activates GABAergic neurons in the ArcN that coexpress neuropeptide Y (Npy) and agouti 
gene–related peptide (Agrp) to stimulate feeding (8). Direct activation of Agrp-expressing 
neurons by using optical or chemical genetic tools leads to ravenous eating (9, 10). Signals 
that strongly repress feeding include insulin, which is released from the pancreas, and the 
cytokine leptin, which is produced by white adipose tissue; both of these activate arcuate 
neurons that coexpress pro-opiomelanocortin (Pomc) and cocaine- and amphetamine-
regulated transcript (Cart). In addition, both leptin and insulin inhibit the activation of 
orexigenic Agrp neurons. The opposing actions of Pomc- and Agrp-expressing neurons are 
further amplified by a reciprocal inhibitory local circuit, with Agrp acting as an inverse 
agonist of melanocortin receptor 4 (Mcr4), the principal effector of the Pomc cleavage 
product α-melanocyte-stimulating hormone (α-MSH). In turn,Mcr4 activation inhibits 
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excitation of Agrp neurons (11). The resulting bistable circuit allows for robust and stable 
internal representation of hunger and satiety and enables rapid transition between these two 
physiological states in response to internal hormonal signals.
Both Agrp and Pomc neurons directly project to multiple neuronal subtypes in the 
hypothalamic paraventricular nucleus (PvN). Inhibition of oxytocin (Oxt)-expressing PvN 
neurons by Agrp neurons is both necessary and sufficient for acute induction of feeding 
(10). Oxt neurons in turn send descending projections to the dorsal vagal complex (DVC) of 
the medulla, which in turn controls the action of the peripheral nervous system to produce 
the somatic manifestations of hunger and satiety. The DVC includes the nucleus of the 
tractus solitarius (NTS) and the area postrema, a circumventricular organ that, like the 
hypothalamic median eminence (ME), lies outside the blood-brain barrier. Pomc is 
expressed in a subset of NTS neurons, which, like ArcN neurons, are leptin responsive (12, 
13). Taste and other sensory inputs required for feedback regulation of digestive, respiratory, 
and cardiovascular organs are conveyed to the central nervous system by visceral sensory 
ganglia, which converge at the NTS. Descending parallel inhibitory projections to the DVC 
are also relayed through unidentified neurons in the lateral hypothalamus (LH), where both 
Pomc-positive cells and Agrp-positive cells send prominent projections. LH lesions that 
affect these descending efferents typically induce anorexia, whereas disruption of 
descending PvN efferents results in hyperphagia and obesity (14, 15). Agrp neuron 
innervation of the pontine parabrachial nucleus (PBN) is necessary but not sufficient for 
acute feeding (10, 16) and may be required to suppress descending glutamatergic projections 
from both the PBN and DVC that induce visceral disgust and inhibit feeding (17).
Other intrahypothalamic Agrp and α-MSH projections may also play important roles in 
modulating food intake. α-MSHergic efferents to the ventromedial hypothalamus (VMH) 
trigger release of brain-derived neurotrophic factor (Bdnf), which suppresses feeding (18), 
whereas reduction in α-MSHergic signaling to the dorsomedial hypothalamic nucleus 
(DMH) can trigger hyperphagia (19). Neurosecretory PvN cells also play a critical role in 
body weight homeostasis downstream of Pomc and Agrp signaling by regulating thyroid 
function through the release of thyrotrophin-releasing hormone (Trh).
Finally, the neural networks that control hunger and satiety are connected to central reward 
circuitries through the ventral tegmental area (VTA) and the nucleus accumbens (NAcc), 
which are connected by dopaminergic projections of the basal forebrain bundle that pass 
directly through the ventral hypothalamus. Ghrelin directly targets the VTA to increase 
motivation to eat (20), whereas both leptin and insulin act in the VTA to suppress hedonic 
feeding and reward-associated food intake (12, 21). Insulin may elicit these behavioral 
changes by directly stimulating reuptake of dopamine, thereby potently reducing synaptic 
dopamine levels (22). Other projections that target the VTA and suppress feeding include α-
MSHergic projections from the ArcN (23, 24) and oxytocinergic projections from the PvN 
(25). α-MSHergic projections also extend to the NAcc and suppress feeding during chronic 
psychological stress (26). Figure 1 summarizes the central neural circuitry regulating 
feeding and appetite.
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DEVELOPMENT OF CENTRAL FEEDING CIRCUITRY IN MAMMALS
Patterning and Cell Fate Specification in the Developing Hypothalamus
The hypothalamic primordium is initially patterned by sonic hedgehog (Shh) secreted by the 
prechordal plate (PCP), the anteriormost extension of the notochord (27). PCP-derived Shh 
induces Shh expression in the hypothalamic floor plate, which in turn induces expression of 
bone morphogenetic protein 7 (Bmp7) in ventral hypothalamic neuroepithelium (28). Bmp7 
then both suppresses ventral Shh expression and induces Shh expression in the more dorsally 
located basal plate domain (Figure 2a). Basal plate–derived Shh both drives progenitor 
proliferation and maintains identity of anterior and tuberal hypothalamic nuclear primordia 
(Figure 2b) (29, 30). Wnt signaling is required for initial specification of hypothalamic 
primordium (31) and later for specification of posterior hypothalamic structures (32).
Nucleogenesis and Cell Fate Specification in the Developing Hypothalamus
Multiple transcription factors are required for different stages of ArcN development. Shh 
signaling induces NK2 homeodomain 1 (Nkx2.1) expression in posterioventral hypothalamic 
progenitors; loss of Nkx2.1 blocks the development of hypothalamic nuclei in this region, 
including VMH and ArcN (Figure 2c) (33). The paired-type homeodomain Rax is also 
expressed in early hypothalamic progenitors and is necessary to maintain expression of both 
Nkx2.1 and Pomc, along with that of the VMH marker gene Nr5a1, which encodes SF-1 
(34).
Transcription factors expressed in progenitors that give rise to the VMH and ArcN also 
control terminal differentiation of both structures. For example, Nr5a1 is selectively 
required for normal development of the VMH. Although VMH neurons are generated in 
normal numbers in Nr5a1 mutants, VMH cellular organization is abnormal, as are its 
afferent and efferent projections. Nr5a1-deficient animals fail to express Bdnf in the VMH, 
which potently suppresses feeding, and both embryonic deletion and postnatal deletion of 
Nr5a1 in the VMH lead to leptin resistance and obesity (35). The homeobox factor Otp is 
also prominently expressed in ArcN progenitors, with loss of function leading to 
hypocellularity (36).
The onset of neurogenesis, which begins at approximately embryonic day (E)10.5 in the 
mouse (37), triggers expression of the neurogenic basic helix-loop-helix (bHLH) factors 
Ascl1 (Mash1), Ngn3, and Nhlh2 in both the ArcN and VMH. These bHLH proteins control 
the development of specific subsets of neurons in the ArcN and VMH (Figure 2d). Ascl1−/− 
mice show a reduction of more than 90% in Nr5a1-, Pomc-, and Agrp-expressing neurons 
(38). Genetic fate mapping reveals that Ngn3-expressing progenitors give rise to subsets of 
Pomc-, Npy-, and Nr5a1-positive neurons in the ArcN and VMH. Furthermore, deletion of 
Ngn3 reveals that it normally promotes the development of Pomc- and Nr5a1-positive 
neurons while inhibiting the development of Npy neurons (39), consistent with the recent 
finding that selective loss of Ngn3 in the developing hypothalamus of Ngn3 results in early-
onset obesity due to hyperphagia (40). Similarly, loss of Nhlh2 results in obesity (41), with 
Nhlh2−/− mice exhibiting a reduction in MSH processing caused by defective expression of 
prohormone convertase-1 in Pomc neurons (42). The homeodomain transcription factor 
Lee and Blackshaw Page 4
Annu Rev Physiol. Author manuscript; available in PMC 2015 July 23.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
encoded by Bsx, which is prominently expressed in the developing ArcN (43), is required 
for normal Npy and Agrp expression (44). However, although Bsx−/− mice show reduced 
food intake, overall body weight is unaffected, implying that compensatory changes take 
place elsewhere in the central feeding circuitry (45).
Relatively little is known about extrinsic factors that influence neuronal subtype identity in 
the developing ArcN, with the exception of a recent finding that Bmpr1a-dependent activin 
signaling is critical for the development of Agrp- and Npy-positive neurons; to a lesser 
extent, this same signaling pathway also affects the development of other ArcN cell types 
(46). Mice lacking Bmpr1a expression in ArcN neuronal precursors develop severe anorexia 
(46), although because the Olig1-Cre line used in this study is expressed in many other 
regions of the developing brain, it is unclear whether anorexia results directly from the 
observed defects in ArcN development. An intriguing study mapping the Pomc-expressing 
cell lineage in the ArcN revealed that a subset of Pomc-expressing cells switch to expressing 
Agrp beginning at approximately E14, with nearly 25% of adult Agrp-expressing neurons 
deriving from Pomc-positive precursors (47). This switch from anorexigenic to orexigenic 
identity may be under the control of extrinsic factors and may be one way in which 
gestational under- or overfeeding regulates cell composition in the ArcN.
The transcriptional network controlling PvN neuroendocrine cell development is much 
better understood than for other regions of the hypothalamus. The Per-Arnt-Sim family gene 
Sim1 is expressed in PvN progenitors beginning at approximately E10.5 (Figure 2c). 
Although Sim1−/− mice lose essentially all neurosecretory cell markers, Sim1 gene dosage 
differentially affects the development of neuroendocrine cell types, with a selective 
reduction in Oxt- and Avp-positive cell numbers in Sim1+/− mice (Figure 2d) (48, 49). Sim1 
haploinsufficiency causes obesity in both humans (50) and mice (51). In contrast, Sim1 
overexpression in PvN can partially reverse weight gain induced by high-fat diet (HFD) or 
by defective Mcr4 signaling (52). Sim1+/− mice exhibit defective descending oxytocinergic 
PvN projections to the NTS; these animals are also hypersensitive to Oxt (48, 49). 
Furthermore, postnatal Sim1 deletion also results in obesity by 12 weeks of age due to 
hyperphagia (53), thus implying that metabolic defects in Sim1-deficient mice may be 
attributable in part to Sim1’s role in the maintenance of cell identity and function. Taken 
together, these findings imply that the loss of descending Oxt projections from the PvN 
partially mediates the effects of Sim1 haploinsufficiency on body weight and suggest that 
restoring the full complement of Sim1 activity may offer a possible treatment for morbidly 
obese individuals harboring one of these rare Sim1 mutations.
Other transcription factors controlling PvN neuroendocrine cell differentiation act both in 
parallel and downstream of Sim1. Otp is a factor that is expressed in PvN progenitors and 
acts independently of Sim1 to control terminal differentiation of PvN neuroendocrine cells; 
this function is in addition to Otp’s role in ArcN development (36, 54). Arnt2 is an 
obligatory heterodimer of Sim1 for both DNA binding and transcriptional activation, with 
Arnt2 mutants phenocopying Sim1 loss of function (55, 56). The Sim1 homolog Sim2 acts 
downstream of Sim1 to promote the development of Trh- and somatostatin (Sst)-expressing 
neuroendocrine cells (Figure 2d) (57). Brn2 is a critical downstream target of Sim1 and 
Arnt2, as evidenced by the selective loss of Crh-, Oxt-, and Avp-expressing PvN and 
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supraoptic nucleus neurons. Unfortunately, an assessment of behavioral and metabolic 
parameters in Brn2-null mice is precluded by their early neonatal lethality (58, 59).
Although the past few years have seen much progress in our understanding of the molecular 
pathways regulating the specification of neurons in the central feeding circuits, much 
remains unknown. For example, nothing is known about the extrinsic molecular factors 
controlling neuroendocrine cell development or about the transcriptional networks guiding 
the differentiation of neurons in the LH, which also play important roles in regulating 
feeding. Moreover, with the notable exception of the trophic actions of leptin and insulin, 
which are discussed below, we are likewise ignorant of the molecular pathways affecting 
axonal pathfinding and synaptogenesis during later stages of the formation of these neural 
circuits. However, recent large-scale gene expression screens have identified large numbers 
of both transcription factors and growth and differentiation factors dynamically expressed in 
all major hypothalamic nuclei, providing a rich source of candidate genes for future studies 
(30).
Postnatal and Adult Hypothalamic Neurogenesis
The induction of neurogenesis is a potential mechanism by which central feeding circuitry 
can enduringly adapt to nutritional availability. Although evidence for neural progenitor 
cells in the juvenile hypothalamus and adult hypothalamus is rapidly mounting (60–62), the 
identity, location, and precise functions of neural progenitor cells in the postnatal 
hypothalamus are controversial.
Recent studies suggested that tanycytes, a radial glial-like ependymal cell that lines the 
ventral portion of the third ventricle, are a potential source of adult-born neurons (Figure 3) 
(63). Tanycytes express many genes selectively enriched in embryonic hypothalamic 
progenitors and adult neural stem cells of the subventricular zone of the lateral ventricles 
and the subgranular zone of hippocampal formation (30, 60, 64). This tanycyte cell 
population is divided into four subtypes, α1, α2, β1, and β2, which can be distinguished by 
functional differences, position, the expression of differentially important functional 
molecules and receptors, and ultrastructure (64). Circumstantial evidence implicating 
tanycytes as potential neural progenitors first arose from in vitro neurosphere or stemness 
assays using tissue obtained from the lining of the hypothalamic third ventricle (65, 66). 
Subsequent prospective genetic-fate-mapping studies demonstrated that one tanycyte 
subtype, the β2 tanycyte, generates neurons in the ME of juvenile mice, providing direct in 
vivo evidence that tanycytes are neurogenic (60). Tanycyte neurogenesis is regulated by 
nutrient availability, as HFD selectively stimulated neurogenesis in both juvenile and young 
adult murine ME (Figure 3a), whereas focal irradiation of the ME attenuated weight gain 
when young adults were fed HFD (60). Although this study reported little evidence that 
other tanycyte subtypes were substantially neurogenic, lineage analysis using Fgf10-CreER 
knock-in mice showed that a substantial number of hypothalamic neurons were derived from 
α2 and β1 tanycytes of the ArcN (67). These differences may arise from the use of different 
ages and inducible Cre lines, with the Fgf10-CreER mouse line used in this study showing 
modest but potentially confounding ectopic recombination in hypothalamic parenchymal 
neurons and glia (67). Another recent study, in which prospective lineage analysis was 
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conducted by using a Glast-CreER transgene, also demonstrated that α tanycytes can give 
rise to both neurons and glia in adult hypothalamus, although the fact that this line does not 
express Cre in β tanycytes precluded a direct analysis of the contribution of this cell type to 
adult hypothalamic neurogenesis (68).
Evidence exists for a slowly proliferating neural progenitor population among neurons and 
glial parenchymal cells of the adult mouse hypothalamus. The suggestion that constitutive 
neurogenesis occurred throughout adult forebrain parenchyma was initially supported by 
widespread BrdU incorporation into neurons in the striatum, thalamus, and hypothalamus 
following continuous intracerebroventricular (icv) delivery of Bdnf and bromodeoxyuridine 
(BrdU), a nucleotide analog incorporated into replicating DNA (69). Later, increased 
hypothalamic neurogenesis was reported in studies of icv delivery of ciliary neurotrophic 
factor (Cntf) to the lateral ventricles. Moreover, simultaneous icv delivery of AraC, which 
inhibits cell proliferation, blocked the effects of Cntf (70). Other studies found that both 
long-term HFD (71) and activation of the nuclear factor κB (NFκB) cytokine signaling 
pathway (72) inhibit BrdU incorporation into hypothalamic Pomc neurons. Furthermore, 
enhancing NFκB signaling impairs survival and differentiation of a Sox2-positive candidate 
neural progenitor cell population in ArcN parenchyma and results in increased food intake 
and body weight at 10 months post–gene delivery. Taken together, these findings suggest 
that parenchymal hypothalamic neurogenesis may primarily generate anorexigenic neuronal 
subtypes and attenuate diet-induced increases in body weight.
Although studies concerning hypothalamic parenchymal neurogenesis triggered 
considerable excitement about the potential modulation of hypothalamic neural circuitry by 
de novo neurogenesis, some caution is necessary in interpreting these findings. Importantly, 
the extensive number of labeled BrdU+ neurons is seen only when BrdU is continuously 
delivered by icv, but not with intraperitoneal or oral delivery pulses of BrdU. The sparse 
number of BrdU-labeled neurons observed with these more conventional delivery routes 
indicates that the overwhelming majority of BrdU+ cells in forebrain parenchyma are NG2+ 
oligodendrocyte precursors rather than neurons (73). These discrepant results using either 
pulses or continuous BrdU delivery may suggest that BrdU+ neurons in hypothalamic 
parenchyma derive from exceptionally slowly proliferating progenitors or, alternatively, 
may reflect BrdU incorporation independent of cell division. Indeed, DNA synthesis can be 
initiated independently of mitosis during gene duplication, repair, or apoptosis (74, 75), 
implying that all dividing cells incorporate BrdU but that not all cells labeled with BrdU 
necessarily divide. Furthermore, continuous BrdU long-term infusion may pose a toxicity 
risk to hypothalamic neurons and increase BrdU incorporation due to increased DNA repair 
(76).
Recent evidence suggests that Sox2+ cells may be a parenchymal source of adult-born 
hypothalamic neurons. Viral tracing studies that marked Sox2+ cells by using a lentiviral 
construct expressing Cre recombinase under the control of the Sox2 promoter concluded that 
newborn parenchymal hypothalamic neurons derive from a Sox2+ progenitor pool (72). 
However, the fidelity of this particular virally delivered Sox2-Cre reagent has not been 
clearly demonstrated in vivo. Revisiting this question using Sox2-CreERT2 knock-in mice, 
which fully recapitulates Cre-mediated recombination from endogenous Sox2 (77), may 
Lee and Blackshaw Page 7
Annu Rev Physiol. Author manuscript; available in PMC 2015 July 23.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
resolve this question. Thus, unlike tanycytic neurogenesis, the identity of a putative 
parenchymal neural progenitor cell(s) remains to be definitively determined.
Studies reporting tanycyte neurogenesis rest on firmer ground, having used mutant mice in 
which inducible Cre recombinase is selectively expressed in tanycytes for prospective 
lineage mapping (60, 67). However, focal irradiation of HFD-fed mice performed in these 
studies (60) blocked not only neurogenesis, but also generation of all cell types in the ME. 
Intersectional genetic approaches to selectively disrupt tanycyte-derived neurogenesis will 
be needed to definitively prove the importance of this process in regulating body weight and 
metabolism (78).
Development of Brain Stem Components of Feeding Circuitry
The molecular mechanisms regulating the development of brain stem circuitry involved in 
feeding are even less well understood than those controlling hypothalamic development. The 
homeodomain transcription factor encoded by Phox2b controls the development of both the 
NTS and its visceral sensory ganglia afferent regions (79). Genetic fate mapping reveals that 
Phox2b acts in peripheral sensory neurons to promote visceral identity while repressing 
somatosensory identity (80). The neurogenic bHLH factor encoded by Olig3 is required for 
NTS neuronal development (81). Neurogenesis has also been reported in area postrema of 
adult mice, a circumventricular organ like the hypothalamic ME, although its regulation by 
dietary signals and its role in regulating feeding are unclear (82, 83).
DISORDERS THAT DISRUPT DEVELOPMENT OF CENTRAL FEEDING 
CIRCUITRY
Genetic variants that regulate body weight and metabolism can also disrupt the development 
of central feeding circuitry. These variants include not only the rare mutations mentioned in 
the previous section, which play central roles in hypothalamic development, but also a range 
of syndromic and single-gene disorders known or suspected to disrupt hypothalamic 
development. One of the best-characterized examples of syndromic developmental obesity is 
Prader-Willi syndrome (PWS), the prevalence of which ranges from 1:15,000 to 1:30,000 
(84). Among multiple other neurological and behavioral disturbances, the disorder presents 
with uncontrolled hyperphagia and an obsession with food beginning at approximately 2–8 
years of age (84). If food intake is not controlled externally, body mass increases and 
progresses to obesity and, eventually, to diabetes (85). Serum ghrelin is already elevated in 
PWS (86) by the first year of life, preceding the onset of hyperphagia (87).
Co-occurrence of hyperphagia with central hypogonadism and small stature suggests that 
disrupted hypothalamic development is a central etiology of PWS (88). Most cases result 
from a 5–7-Mb deletion in paternally inherited chromosome 15q11.2-q13, which contains 
multiple genes subject to parental imprinting. Loss-of-function mouse models of some of 
these imprinted genes have given insight into the genetic underpinnings of PWS. Mice 
deficient in Magel2 or Necdin (Ndn) demonstrate features reminiscent of PWS and strongly 
support the hypothesis that PWS results from aberrant hypothalamic development. Ndn−/− 
mice have profound deficits in some hypothalamic neuronal subtypes (89); similarly, 
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Magel2−/− mice have fewer Agrp-positive neurons, excessive weight gain after weaning, and 
altered adult metabolism (90, 91). Despite these genetic insights, considerable controversy 
due to the variable penetrance of PWS remains, with patient studies indicating that deletions, 
including those of MAGEL2 and NDN, may not be sufficient to cause disease (92). These 
conflicting results may be explained by interactions of PWS genes with maternally derived 
genetic modifiers (93), although the relevant genetic variants remain unidentified.
Other individual genes that control hypothalamic development have also been proposed to 
underlie obesity and related metabolic disorders. One such gene is delta-like 1 homolog 
(Dlk1), a transmembrane protein that is homologous to the Delta family of Notch ligands 
and that acts as a noncanonical Notch signaling inhibitor in vitro (94). Like Magel2 and 
Ndn, Dlk1 undergoes parental imprinting and is prominently and selectively expressed in 
both the developing hypothalamus and the adult hypothalamus (95). Loss of function of 
paternally inherited human DLK1 leads to extreme child and adolescent obesity (96). 
Likewise, increased adiposity and obesity are seen in mice heterozygous for a paternally, but 
not maternally, inherited mutant allele of Dlk1 (97).
Bdnf and its receptor TrkB regulate neurogenesis, synaptogenesis, and neuronal survival in 
multiple brain regions. Bdnf is robustly expressed in several hypothalamic regions, with 
haploin-sufficiency leading to early-onset obesity in mice (98). Both BDNF 
haploinsufficiency and TRKB haploinsufficiency similarly lead to early-onset obesity in 
humans (99, 100). The human Val66Met polymorphism decreases BDNF secretion (101) 
and is associated with increased risk of obesity (102, 103). Despite extensive data 
demonstrating an anorexigenic function for Bdnf, its role in hypothalamic development is 
unclear. However, because intrahypothalamic infusion of recombinant Bdnf acutely inhibits 
feeding (104) and restoring Bdnf to the hypothalami of Bdnf-deficient adult mice normalizes 
body weight, any effects of Bdnf deficiency during development are apparently reversible 
later in life. It is unclear whether restoring the function of other obesity-associated genes in 
adulthood can normalize weight, a critical consideration for any targeted gene therapy 
approaches aimed at correcting these defects.
Other genes linked to control of body weight and adiposity in human association studies 
includeFTO(fat mass and obesity–associated gene), which encodes an RNA demethylase 
expressed prominently in the developing hypothalamus and the adult hypothalamus (105). 
FTO couples mT or activity to intracellular amino acid levels (106). Common FTO variants 
are associated with a substantial increase in the risk of early-onset obesity in humans (107), 
and maternal obesity induces Fto mRNA expression in neonatal, but not adult, offspring 
(108). Other genes associated with early-onset obesity in human populations include those 
encoding the protein kinase PRKCH and the cell adhesion molecule NEGR1 and the long 
non coding RNA RMST (109, 110), which are all prominently expressed in the developing 
hypothalamus (30). Negr1-deficient mice show substantially reduced food intake and 
physical activity (111).
Understanding the molecular pathways that mediate hypothalamic development will inform 
our understanding of how inappropriate development of feeding and metabolic circuits 
contributes to the manifestation of metabolic disorders. Such knowledge will allow for the 
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use of genetic biomarkers in formulating treatment plans for metabolic disorders tailored to 
underlying individual disease mechanisms.
EARLY-LIFE ENVIRONMENTAL REGULATION OF ADULT METABOLISM
Although this review thus far focuses on the molecular and genetic mechanisms guiding the 
development of central feeding and metabolic circuitry, dietary factors and hormonal factors 
regulate this process at all stages. Animal and epidemiological studies show that maternal 
nutrition during early critical periods (e.g., gestation and lactation) can produce lasting 
changes in metabolism and physiology of offspring. These early environmental effects on 
adult body weight have been appreciated for at least half a century (4, 112) and have 
matured conceptually into metabolic imprinting theory, initially proposed by Hales & 
Barker (113). These studies systematically demonstrated an elevated risk of diabetes, 
obesity, and cardiovascular disease in offspring of malnourished mothers (114). Such effects 
may reflect adaptive changes by the developing fetus that are aimed at maximizing energy 
utilization in the face of continued poor nutrition following birth, the so-called thrifty 
phenotype hypothesis (113). More recently, it has become clear that overfeeding in early life 
can produce deleterious effects much like those of early malnutrition and that long-term 
effects of early-life nutritional excess or scarcity depend on the timing, duration, and 
severity of the treatment and on the sex of affected offspring (115). This section summarizes 
current knowledge on how nutrient levels during critical developmental periods inform long-
term metabolic changes.
In general, gestational obesity and early postnatal obesity are often sufficient to rewire 
central homeostatic and hedonic regulatory circuitry, leading to increased food intake and 
lower activity rates later in life. Paradoxically, similar effects are also observed with early 
caloric deprivation. When undernutrition during early critical periods is accompanied by 
improved nutrition later, many plants and animals (including humans) display compensatory 
or accelerated catch-up growth. Studies conducted on survivors of the Dutch winter famine 
of 1944–1945 revealed that undernutrition during the first half of pregnancy induced adult 
obesity and T2D in humans (116, 117), despite lower final trimester and early postnatal 
body weight (5). Gestation and birth during postwar famine in Nigeria (118), China (119), 
and Austria (120) likewise led to a dramatic increase in rates of adult T2D.
It has been hypothesized that metabolic changes from early malnutrition arise from 
accelerated catch-up growth, which can bring rapid benefits to the organism at a substantial 
cost later in life (121). This same mechanism may account for the deleterious metabolic 
effects of early overnutrition. Timing of catch-up growth appears to be critical, with a much 
higher incidence of obesity and diabetes noted when catch-up occurs close to weaning age 
(122). In humans, low birth weight coupled with rapid weight gain between ages 3 and 11 
greatly increases the risk of developing T2D (123). Long-term food deprivation not followed 
by abundance, such as during the 3-year-long siege of Leningrad during World War II, does 
not lead to rapid compensatory catch-up growth (124) and is not associated with increased 
obesity or T2D rates in adulthood (125). Furthermore, a longitudinal study of 13,517 men 
and women born at Helsinki University Hospital from 1924 to 1944 suggests that between 
25 and 63% of the incidence risk of adult diabetes, hypertension, and coronary heart disease 
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may be attributed to low birth weight and/or to accelerated newborn-to-adolescent weight 
gain (123).
Gestational and Postnatal Undernutrition
Although maternal undernutrition can elevate obesity andT2Drisk in offspring, this effect 
depends on the timing and duration of caloric restriction. Undernutrition during the first half 
of human pregnancy increases obesity risk in offspring, whereas undernutrition during the 
final trimester or first few postnatal months is associated with lower adult body weight (5). 
Fetuses exposed to nutritional deprivation have impaired glucose tolerance (116) and higher 
food intake and adiposity (126, 127). Nutritional deprivation in animal models reduces 
sympathetic innervation of white adipose tissue in male, but not female, mice (128). 
Gestational caloric restriction increases cell proliferation in the PvN, VMH, ArcN, and ME 
in the early postnatal period, most likely reflecting increased gliogenesis or ongoing reactive 
gliosis (129). However, a 20% caloric restriction during early gestation (E1–12) in rats 
reduces both Npy and Pomc neuron numbers in the ArcN, along with decreases in both 
LepR and InsR mRNA(130). Caloric restriction likewise blunts the postnatal surge in leptin 
and inhibits the formation of ArcN-PvN melanocortinergic projections (131). Maternal 
malnutrition during lactation can likewise have detrimental effects on offspring and is 
associated with higher risks of obesity and leptin resistance (132).
Gestational and Early Postnatal Overnutrition
Recent reports of an association between excessive weight in human pregnancy and the BMI 
of adolescent children support the developmental overnutrition hypothesis, suggesting that 
maternal obesity may predispose offspring to increased obesity risk (133, 134). Animal 
studies confirmed maternal obesity as causal for elevated adult hyperphagia and obesity in 
progeny (135). Neonatal offspring of obese dams display amplified and prolonged leptin 
surges, which may remodel postnatal central feeding circuitry (136). Hypothalamic Fto 
mRNA expression is also upregulated by maternal obesity, and the level of such expression 
is correlated with higher visceral fat in adulthood (108). Early neonatal overfeeding is 
likewise a risk factor for adult obesity and metabolic disorders, leading to leptin resistance 
(137), consistent with higher hypothalamic SOCS3 expression and lower STAT3 activity 
levels in adult rats; both of these transcription factors participate in leptin signaling (138). 
Moreover, in rodents, the metabolic risks of maternal obesity and postweaning HFD 
consumption are additive and cumulative (139).
Gestational Diabetes
In a similar vein, offspring of diabetic mothers are predisposed to obesity and T2D later in 
life. As in humans, murine gestational diabetes (GD) elevates body weight of offspring 
(140) and reduces mean neuronal areas in both the PvN and the VMH (141). More Npy-
positive neurons were observed in the ArcN of both neonatal and adult offspring of GD 
mothers (141). Neural projections from the ArcN to the PvN are also markedly reduced in 
progeny of insulin-deficient dams (140). These data show that GD leads to structural 
changes in central feeding circuitry.
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Dietary Signals that Control Development of Central Feeding Circuitry
Epidemiological studies indicate that low maternal intake of dairy and meat protein in late 
pregnancy is associated with low birth weight (142). In animal models, a gestational low-
protein diet (LPD) also results in offspring with lower body weight, as well as in 
hypoglycemia and hypoinsulinemia (143). Significant structural changes in the hypothalami 
of LPD dams’ progeny include increased VMH volume and increased VMH and PvN 
neuron density; both the PvN and the LH also showed increased Npy and Agrp 
immunoreactivity (129, 143, 144). Although a minimal amount of maternal protein intake is 
necessary for proper central-feeding-circuitry development, excessive dietary protein in 
early life likewise has long-term deleterious effects on metabolism. In animals, a gestational 
high-protein diet (HPD) leads to increased adiposity and to decreased energy expenditure in 
adult offspring (145), and epidemiological studies suggest that similar effects may occur in 
humans (146).
A high-carbohydrate diet (HCD) during gestation induces leptin and insulin resistance and 
increases Npy and Agrp mRNA expression in the ArcN. However, in contrast to HPD and 
HFD, HCD does not increase offspring weight gain (147). Supplementation of maternal 
diets with 20% fructose have yielded inconsistent metabolic effects in offspring; one study 
reported elevated blood leptin and glucose in P10 female rat pups, but not in male rat pups, 
although whether this effect persisted into adulthood was unclear (148). Another study 
reported high body weights in adult offspring of mothers fed 20% fructose during gestation 
(149). It is uncertain whether any observed long-term effects of carbohydrate 
supplementation resulted from carbohydrates per se or simply from excess caloric intake, as 
control diets tested in these studies were not isocaloric. The pressing need for additional 
studies on this topic is highlighted by multiple epidemiological studies that link increased 
consumption of high-fructose corn syrup with elevated childhood obesity rates, suggesting a 
possible effect of this supplement on metabolic imprinting (150, 151).
In contrast, it is well established that maternal HFD is a major trigger for long-term 
deleterious effects on progeny body weight and metabolism (152). HFD increases protein, 
cholesterol, and triglyceride content in breast milk, elevating total caloric and fat intake in 
nursing pups (153). In rats, maternal HFD during gestation or nursing increased body 
weight, adiposity, food consumption, and plasma leptin concentration in pups and led to 
impaired glucose tolerance and leptin resistance (154). Some studies reported these effects 
to be sexually dimorphic, with increased adult adiposity and hyperphagia observed only in 
male progeny, although impaired glucose tolerance occurred in offspring of both sexes (153, 
154). In contrast, other studies reported no sex differences in these effects (155).
High-Fat Diet and Regulation of Embryonic and Postnatal Neurogenesis
HFD appears to mediate long-term effects on feeding through controlling the generation and 
differentiation of hypothalamic neurons. The offspring of pregnant rats fed HFD between E6 
and P15 showed elevated hypothalamic cell proliferation at E14, as measured by BrdU 
incorporation. At later time points, offspring exposed to HFD showed selective increases in 
neuronal number in the PvN and the LH, but not in the ArcN. Selective increases in the 
number of galanin- and dynorphin-expressing cells were observed in PvN, along with 
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increases in orexin in the LH and increases in body weight and adiposity (155). Because 
these neuropeptides are sometimes orexigenic, these findings suggest that embryonic HFD 
may stimulate the production of neurons that promote food intake.
Several recent studies reported that HFD also controls neurogenesis in the postnatal 
hypothalamus, although other studies report opposing effects of HFD on neurogenesis and 
body weight. One possible explanation for this apparent contradiction is differences in the 
ages and sexes of the animals tested, as Li et al. (60) examined 3–6-month-old males, 
whereas Lee et al. (72) examined 6–11-week-old females. Furthermore, the two studies 
targeted different hypothalamic regions, suggesting that hypothalamic parenchymal neural 
progenitors may predominantly generate anorexigenic neurons, whereas ME tanycytic 
neural progenitors may predominantly generate orexigenic neurons. In addition, Li et al. 
(60) examined mice exposed to HFD over several months, while Lee et al. (72) administered 
HFD for only one month. The recent finding that HFD induces a rapid and transient 
stimulation of neurogenesis in ventrobasal hypothalami of adult female mice, as measured 
by BrdU incorporation (156), may underlie the increase in neurogenesis in ME observed by 
Lee et al. (72). Finally, different hypothalamic neural progenitor pools may produce 
different sets of anorexigenic or orexigenic neurons in response to changes in nutritional 
availability, which would also explain the different physiological and inflammatory 
responses to acute versus chronic HFD (157). These newly adult-born neurons may respond 
to short-term changes in nutrient availability and may ultimately affect long-term energy 
homeostasis (158).
Diet-Regulated Hormonal Signals
Changes in gestational or early postnatal diet may trigger long-term changes in feeding 
regulatory circuitries by affecting known hormone signaling pathways involved in energy 
homeostasis. Among these, the most heavily studied hormones are leptin and insulin, which 
are tightly regulated by fatty acid and carbohydrate levels, respectively. Leptin readily 
crosses the placenta (159), relaying maternal dietary status to the fetus. In contrast, insulin 
crosses the placenta poorly (160), but because insulin is produced in fetal pancreatic β cells 
before most hypothalamic neurogenesis begins, it can potentially regulate the earliest stages 
of central-feeding-circuitry development. Both leptin and insulin promote proliferation in 
neurosphere cultures of fetal rat hypothalamus, whereas low birth weight leads to depletion 
of hypothalamic neural progenitor cells in neurosphere assays (161, 162). Furthermore, 
intrahypothalamic infusion of insulin in neonatal rats led to a decrease in neuronal cell size 
in the VMH, with a corresponding increase in neuronal size in the DMH, indicating that 
hypothalamic nuclei important for regulating feeding exhibit a differential susceptibility to 
the developmental effects of insulin signaling (163).
Leptin plays a critical neurotrophic role for ArcN projection neurons. In rodents, ArcN 
projections are immature at birth and innervate, in succession, the DMH, PvN, and LH 
within distinct temporal windows (164). Axonal outgrowth and pathfinding from the ArcN 
to the PvN are leptin dependent (136), with innervation coinciding with a dramatic increase 
in circulating leptin levels during the second postnatal week in mice (165). Absence of leptin 
during this stage disrupts the formation of axonal projections from the ArcN to the PvN 
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(136), whereas a premature surge in leptin levels increases the density of these projections 
(166). Leptin exerts different effects on the targeting of Agrp and Pomc axonal projections: 
Leptin-deficient mice exhibit reduced Agrp and Pomc innervation of PvN neuroendocrine 
cells, whereas only Agrp innervation of preautonomic NTS neurons is affected in these 
animals. Leptin also induces rapid changes in the strength and number of excitatory and 
inhibitory synapses contacting ArcN neurons that express either Npy or Pomc; the opposite 
effects are observed with ghrelin (167).
Leptin regulates hypothalamic circuitry development by different signaling mechanisms 
downstream of the leptin receptor (LepR), activating both Stat3 phosphorylation and 
PI3K/Akt/Erk signaling. The formation of Agrp projections to the PvN requires LepR-
dependent activation of both Stat3 and Erk1/2, whereas leptin-dependent formation of Pomc 
projections requires only Stat3 phosphorylation (168). LepR-dependent phosphorylation of 
Stat3 triggers the nuclear entry of Stat3, allowing it to activate transcription. Erk and Akt 
signaling in turn triggers phosphorylation of the transcription factor FoxO1 and inhibits 
nuclear entry of Stat3. Erk and Akt act in a mutually antagonistic manner in appetite-
regulating neurons of the ArcN. FoxO1 directly activates transcription of Agrp and inhibits 
Stat3-dependent activation of Pomc transcription, whereas Stat3 in turn inhibits Agrp 
transcription (169).
Hypothalamic Inflammation and Cellular Stress
Recent studies observed elevated levels of circulating cytokines and adipokines prior to the 
induction of overnutrition-related diseases such as obesity andT2D(170, 171), suggesting 
that metabolic inflammation may be a cause, rather than just an effect, of metabolic diseases 
(172). This hypothesis is supported by animal studies showing increased proinflammatory 
cytokine (IL1β, IL6, TNFα) and Nfκb pathway gene expression in the hypothalamus, along 
with an induction of reactive hypothalamic gliosis, shortly after introduction of HFD (3–
7days) (157, 173). Central activation and inactivation of Nfκb signaling in the mediobasal 
hypothalamus show that this pathway plays a central role in regulating body weight (174). 
Selective activation of Nfκb signaling in putative neural progenitors in ArcN parenchyma 
inhibits adult neurogenesis, pointing to one potential pathway by which hypothalamic 
inflammation can trigger long-term changes in body weight (72).
Although a proinflammatory environment precedes the incidence of overnutrition-related 
diseases in adolescence and adulthood, it remains unclear how Nfκb and cytokines might 
modulate central-feeding-circuitry development during maternal overnutrition. In adult 
mice, Nfκb signaling inhibits the expression of Socs3, a critical inhibitor of both insulin 
signaling and leptin signaling in the hypothalamus (174). HFD likewise downregulates 
hypothalamic Socs3 expression, a process that occurs at least in part through activation of 
the endoplasmic reticulum (ER) stress response (174). Interestingly, direct pharmacological 
activation of the ER stress response through icv administration of thapsigargin blocks the 
anorexigenic effects of both leptin and insulin; such a mechanism involving a change in the 
ER stress response may underlie leptin resistance associated with overnutrition (175). As in 
adults, exposure to maternal circulating cytokines may help program metabolic neural 
circuits in the developing fetal hypothalamus. Maternal overnutrition may also activate 
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hypothalamic Nfκb signaling, leading to insulin and leptin resistance, which may in turn 
trigger long-lasting epigenetic changes in hypothalamic neurons regulating feeding and 
metabolism (176, 177). Thus far, however, the precise mechanism by which a dietary 
increase in fatty acids leads to systemic hypothalamic inflammation remains to be 
determined.
Psychosocial Stress and the Hypothalamic-Pituitary-Adrenal Axis
Accumulating evidence suggests that gestational stress or early postnatal stress increases the 
susceptibility of offspring to diet-induced obesity and metabolic disorders (178, 179). 
Elevated stress—which may be dietary, physical, or psychological—increases energy 
storage through multiple mechanisms. Stressed pregnant dams give birth to offspring that 
gain more weight and have greater adiposity than do control littermates. Consistent with 
their body composition, offspring of stressed dams are hyperleptinemic and 
hyperinsulinemic at weaning. However, these effects are reversible: Weaning onto a 
standard chow diet reverses early signs of obesity. Metabolic effects of perinatal stress are 
likely mediated by increases in the hypothalamic releasing hormone Crh and the subsequent 
elevation of glucocorticoids, which acutely influence food intake levels (180) and can 
chronically induce the symptoms of metabolic syndrome, including glucose intolerance, 
hyperlipidemia, and hyperinsulinemia (181).
Epigenetic Regulation of Metabolic Imprinting
Developmental epigenetic modification of genes important for the function of central 
feeding circuitry may be a critical mechanistic component of metabolic imprinting. In 
maternal undernutrition studies of pregnant sheep, offspring had reduced DNA methylation 
of the Pomc and glucocorticoid receptor (Gr) promoters. Alterations in Gr methylation were 
restricted to the hypothalamus, with no changes observed in the hippocampus (182). In 
another study, mice exposed to HFD during the embryonic and preweaning periods had 
hypomethylation of the vesicular dopamine transporter (Dat), the µ-opioid receptor (Mor), 
and preproenkephalin (Penk) promoters in the brain (183). These effects were associated 
with elevated Dat expression in the VTA, the NAcc, and the prefrontal cortex, but with 
reduced expression in the hypothalamus. There was increased expression of Mor and Penk 
in all these areas, suggesting that hedonic aspects of feeding may be altered in these animals. 
As with most examples of epigenetic changes induced by environmental signals, the 
mechanism by which these modifications are selectively targeted to the regulatory regions of 
these specific genes is unclear.
Reversing the Deleterious Effects of Metabolic Imprinting
Given that early-life exposure to challenging nutritional environments can produce 
deleterious metabolic effects in adulthood, one might ask whether there are any available 
interventional strategies that would mitigate the preclinical risks for metabolic disorders. 
Some studies suggest that low-cost and essentially risk-free environmental changes may 
blunt the developmental effects of metabolic imprinting. For example, a 3-week period of 
wheel running in rats fed HFD in early postnatal life leads to sustained increases in leptin 
sensitivity in adulthood (184). Enriched environmental conditions (EEC) are even more 
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potent in reversing prenatal HFD-induced leptin resistance, triggering ArcN synaptic 
changes that increase Pomc neuron excitability and decrease Agrp neuron excitability (185). 
The impact of EEC is age dependent, with the greatest impact on the leptin-hypothalamic 
axis when environmental stimulation is applied during postnatal development. In 
corroboration, previous studies on the cerebral cortex found that early EEC accelerates 
neuronal maturation through an IGF1-dependent mechanism (186).
EEC may also alter central feeding circuitries by regulating Bdnf expression. Hypothalamic 
Bdnf mRNA is selectively upregulated by EEC, with a 2-week exposure inducing a twofold 
increase in Bdnf expression in the ArcN and VMH of young adult mice (187). Hypothalamic 
Bdnf potently inhibits both feeding and fat storage (18, 188, 189), and hypothalamic 
knockdown of Bdnf blocks EEC effects on circulating leptin levels (187). Pharmacological 
approaches may mimic the effects of early EEC at later stages of development. In the visual 
cortex, fluoxetine administration induces Bdnf expression, restoring ocular dominance 
plasticity in adulthood (190, 191). The prominent role of Bdnf in regulating the development 
and function of central hypothalamic feeding circuitry suggests that a similar, targeted 
approach may prove useful here.
CONCLUSIONS AND FUTURE DIRECTIONS
Our understanding of the neurodevelopmental regulation of metabolism and the central 
mechanisms regulating feeding has exploded in the past decade. We now know the key 
peripheral signals communicating hunger and satiety to the brain, along with at least a subset 
of the first-order hypothalamic neurons that relay these signals. Our understanding of the 
genetics of body weight and hypothalamic development has advanced to the point that clear 
links between defective hypothalamic differentiation and early-onset obesity can be made. 
Finally and most importantly, a plethora of both animal and human studies have 
convincingly established the link between (a) both over- and undernutrition early in life and 
(b) metabolic disturbances in adulthood.
Despite this, much work remains to be done, and we remain ignorant of many fundamental 
aspects of this system and its development. We still know only the barest outlines of central-
feeding-circuitry organization. We are only just beginning to identify postsynaptic targets of 
the Pomc and Agrp neurons of the ArcN and to study their role in regulating feeding and 
satiety. Ghrelin, leptin, and insulin modulate the activity of multiple different neuronal 
subtypes in the hypothalamus and brain stem, and the precise identity of these neurons and 
their role in regulating feeding remain to be determined. Other hypothalamic neuronal 
subtypes are in turn connected to neurons responsive to dietary hormones; ultimately, these 
connections signal hunger, satiety, and the hedonistic aspects of feeding. Finally, virtually 
all studies of central feeding circuitry thus far have focused on identifying cells that acutely 
regulate food intake. However, early-life metabolic imprinting often leads to only modest 
increases in adult food intake that act gradually to increase adult body weight and T2D risk. 
Thus, neuronal subtypes that remain entirely unidentified may control long-term changes in 
food intake. Even with the advent of powerful new tools of optical and chemical genetics 
that allow for reversible and selective activation of individual neuronal subtypes, the 
tremendous molecular heterogeneity of the hypothalamus makes this problem particularly 
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challenging. The availability of public repositories of molecular markers and regional 
connectivity through the Allen Brain Atlas (192), coupled with new technologies for 
comprehensive identification of neuronal subtypes activated by specific physiological 
stimuli (193), will contribute importantly to expanding our understanding of central feeding 
circuitry.
Knowledge of the genetic networks controlling regional specification, cell identity, and 
neuronal connectivity in the hypothalamus and in the brain stem is even less well developed 
than our understanding of central feeding circuitry. The anatomy of these structures is highly 
complex, particularly at the early stages of development. Unraveling the complexity of the 
hypothalamus has historically been hampered by the lack of robust regional and cell 
subtype–specific molecular markers. However, the recent publication of an annotated 
molecular atlas of the developing hypothalamus, along with the release of in situ 
hybridization data for several thousand genes from mouse embryos of multiple different 
developmental stages (30, 194), has gone a long way toward bypassing this roadblock. 
When combined with the availability of conditional alleles for hundreds of genes, 
intersectional genetic approaches can be designed to selectively study how candidate genes 
guide the development of specific cell types that compose the neural feeding circuitry (195, 
196). This intersectional approach can also directly determine the contribution of individual 
neuronal cell types to feeding regulation, provided that mutant animals survive gestation. In 
addition, new, robust assays for feeding and metabolism will allow investigators in the field 
to use powerful genetic tools available in zebra fish (197–199). The next few years will 
likely see much progress both in our understanding of how central neural circuitry 
controlling feeding is assembled during development and in the extent to which genetic 
variants influencing body weight and metabolism disrupt this process.
This work will complement and provide firm mechanistic insight into the flood of human 
genetic data now being generated. Dozens of both rare and common genetic variants that 
predispose humans to early-onset differences in body weight and metabolism will be 
identified in the next few years, although in most cases how these variants produce these 
changes will be unclear. The same genetic approaches and model organisms used for 
defining the development of central feeding circuitries can also be employed to ask whether 
and how these genetic variations account for juvenile obesity and diabetes.
Finally, despite compelling evidence that gestational and early postnatal dietary signals 
induce long-lasting changes in body weight and metabolism, precisely how the developing 
brain senses nutrient status is still unclear. What are the relative contributions of peripheral 
hormonal signals like insulin and leptin compared with local sensing of metabolites by the 
mTor pathway or, in the case of HFD, by inflammation? When and where these signals act 
are likewise unclear. What are the critical periods in which over- and underfeeding exert 
long-term effects on central feeding circuitry? Do these signals trigger shifts in cell identity, 
neural connectivity, and/or synapse formation?
Knowing precisely where to look for such dietary-induced changes in neuronal 
differentiation is challenging. However, it should become possible to more precisely 
correlate changes in diet and hormonal levels with long-term alterations in feeding circuitry 
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as our understanding of central feeding circuitry expands; as global changes in gene 
expression triggered by dietary signals emerge; and as new technologies develop for the 
rapid visualization of developmental changes in neuronal subtype, connectivity, and 
morphology (200). As these new data converge with a basic understanding of normal 
hypothalamic development and the dietary signaling pathways, the molecular and cellular 
mechanisms mediating metabolic imprinting should ultimately be resolved. This knowledge 
can then serve as the basis for therapies aimed at halting or reversing the public health crisis 
now building as a result of the obesity epidemic.
ACKNOWLEDGMENTS
We thank W. Yap, T. Moran, and J. Bedont for helpful feedback on the manuscript.
Glossary
T2D type 2 diabetes
ArcN hypothalamic arcuate nucleus
Npy neuropeptide Y
Agrp agouti gene–related peptide
Pomc pro-opiomelanocortin
α-MSH α-melanocyte-stimulating hormone
PvN paraventricular hypothalamic nucleus
DVC dorsal vagal complex
NTS nucleus of the tractus solitarius
ME median eminence
LH lateral hypothalamus
VMH ventromedial hypothalamus
Bdnf brain-derived neurotrophic factor
DMH dorsomedial hypothalamic nucleus
Trh thyrotrophin-releasing hormone
VTA ventral tegmental area
NAcc nucleus accumbens
Shh sonic hedgehog
HFD high-fat diet
BrdU bromodeoxyuridine
Cntf ciliary neurotrophic factor
LPD low-protein diet
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HPD high-protein diet
HCD high-carbohydrate diet
EEC enriched environmental conditions
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SUMMARY POINTS
1. Global rates of obesity and comorbid health problems, such as diabetes, 
cardiovascular disease, and cancer, have increased dramatically during the past 
30 years.
2. Both human studies and animal studies have firmly established that 
developmental exposure to either nutritional excess or scarcity results in an 
increased probability of obesity and associated disorders in adulthood, a process 
known as metabolic imprinting. The effects of metabolic imprinting are likely to 
exacerbate and prolong the public health problems resulting from the obesity 
epidemic.
3. The past decade has seen a substantial increase in our understanding of the 
organization of central feeding circuitry and its development. A number of 
transcription factors have been found to be essential for the specification and 
function of the hypothalamic neuronal subtypes that regulate feeding.
4. Postnatal and adult hypothalamic neurogenesis appears to play a critical role in 
controlling feeding.
5. Investigators have identified a range of syndromic and single-gene disorders that 
result in the dysregulation of body weight and metabolism, in part by disrupting 
the development of central feeding circuitry.
6. Nutritional signals affect multiple aspects of hypothalamic development from 
embryonic neurogenesis and cell fate specification to neural circuit formation. 
These signals appear to mediate their effects by diet-regulated hormones such as 
leptin and insulin, as well as by the induction of hypothalamic inflammation.
7. Challenging nutritional environments in early life can produce deleterious 
metabolic effects in adulthood. The use of low-cost and risk-free changes may 
mitigate the preclinical risk for metabolic disorders.
8. Although much progress has been made in recent years, our current 
understanding of all aspects of metabolic imprinting—from the organization and 
development of central feeding circuitry to the mechanisms by which dietary 
signals disrupt neuronal development—is still poor.
Lee and Blackshaw Page 30
Annu Rev Physiol. Author manuscript; available in PMC 2015 July 23.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 1. 
An overview of neural circuitry controlling both appetitive and hedonic aspects of food 
intake is shown. Excitatory synaptic inputs are indicated by arrowheads, and inhibitory 
inputs are indicated by bars. Abbreviations: Agrp, agouti gene–related peptide; ArcN, 
hypothalamic arcuate nucleus; Cart, cocaine- and amphetamine-regulated peptide; CCK, 
cholecystokinin; DA, dopamine; DMH, dorsomedial hypothalamic nucleus; DVC, dorsal 
vagal complex; LH, lateral hypothalamus; ME, median eminence; NAcc, nucleus 
accumbens; Npy, neuropeptide Y; Oxt, oxytocin; PBN, parabrachial nucleus; PfCtx, 
prefrontal cortex; PNS, peripheral nervous system; Pomc, pro-opiomelanocortin; PvN, 
paraventricular nucleus; Trh, thyrotrophin-releasing hormone; VMH, ventromedial 
hypothalamus; VTA, ventral tegmental area.
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Figure 2. 
Molecular mechanisms controlling hypothalamic development. (a) Early hypothalamic 
patterning by prechordal plate–derived sonic hedgehog (Shh) in sagittal sections of mouse 
hypothalamus. (b) Expression of Shh, bone morphogenetic protein 7 (Bmp7), and NK2 
homeodomain 1 (Nkx2.1) in hypothalamic neuroepithelium prior to the onset of 
neurogenesis. (c) Transcription factors required for nucleogenesis and the early stages of 
neurogenesis in hypothalamic nuclei that regulate feeding. (d) Control of neuronal subtype 
specification in the developing PvN and ArcN. Panels a, b, and c are shown in sagittal 
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orientation, whereas panel d is in coronal orientation. Other abbreviations: AdHy, 
anteriodorsal hypothalamus; Agrp, agouti gene–related peptide; ArcN, hypothalamic arcuate 
nucleus; Avp, arginine vasopressin; Crh, corticotrophin-releasing hormone; Di, 
diencephalon; DTh, dorsal thalamus; Hy, hypothalamus; Mes, mesencephalon; Oxt, 
oxytocin; PCP, prechordal plate; Pomc, pro-opiomelanocortin; PrTh, prethalamus; PVH, 
paraventricular hypothalamic nucleus; PVHy, posterioventral hypothalamus; PvN, 
paraventricular nucleus; Sst, somatostatin; Tel, telencephalon; Trh, thyrotrophin-releasing 
hormone; VMH, ventromedial hypothalamus; ZLI, zona limitans intrathalamica.
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Figure 3. 
Potential sources of postnatal hypothalamic neurogenesis. (a) α2 (red) and β1 (yellow) 
tanycytes of the hypothalamic arcuate nucleus (ArcN) and β2 tanycytes (purple) of the 
median eminence (ME) function as neural progenitors, with newborn neurons migrating 
along tanycyte foot processes into the hypothalamic parenchyma. High-fat diet (HFD) 
stimulates neurogenesis from β2 tanycytes of the ME but inhibits neurogenesis in more 
dorsal tanycytic neural progenitors. Factors present in the cerebrospinal fluid (CSF) directly 
contact the apical surface of tanycytes, whereas blood-borne factors contact β2 tanycytes. (b) 
HFD inhibits an as-yet-uncharacterized, constitutively proliferating parenchymal progenitor 
population.
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